Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuejun Chen

Showing results (281-290 of 327) with videos related to

Pageof 33
Sort By:
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Immunity|August 5, 2018
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor AntibodiesHongying Duan, Xuejun Chen, Jeffrey C Boyington, et al.
Science Translational Medicine|July 4, 2014
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorAmarendra Pegu, Zhi-yong Yang, Jeffrey C Boyington, et al.
Cell Host & Microbe|September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV ChallengeAmarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Structure (London, England : 1993)|August 15, 2025
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibodyReda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilityWei Shi, Lingshu Wang, Tongqing Zhou, et al.
Nature|August 15, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionSung-Youl Ko, Amarendra Pegu, Rebecca S Rudicell, et al.
Pageof 33

Showing results (281-290 of 327) with videos related to

Sort By:
Pageof 33
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Immunity|August 5, 2018
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor AntibodiesHongying Duan, Xuejun Chen, Jeffrey C Boyington, et al.
Science Translational Medicine|July 4, 2014
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorAmarendra Pegu, Zhi-yong Yang, Jeffrey C Boyington, et al.
Cell Host & Microbe|September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV ChallengeAmarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Structure (London, England : 1993)|August 15, 2025
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibodyReda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilityWei Shi, Lingshu Wang, Tongqing Zhou, et al.
Nature|August 15, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionSung-Youl Ko, Amarendra Pegu, Rebecca S Rudicell, et al.
Pageof 33